ArticleFrontiers in veterinary science2025
Prevalence and genetic basis of extended-spectrum β-lactamase-producing
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Genomic insights into carbapenemase- and extended-spectrum β-lactamase-producing gram-negative bacteria in aquatic and terrestrial animal reservoirs in the United Arab Emirates.One health (Amsterdam, Netherlands) · 2026Article
- A Systematic Review of β-Lactamase and Carbapenemase-ProducingVeterinary sciences · 2026Review
- Antimicrobial resistance in poultry meat in the mediterranean region: prevalence, public health implications, and control strategies: A review.Poultry science · 2026Review
- Widespread Multidrug Resistance and Virulence Determinants inAntibiotics (Basel, Switzerland) · 2026Article
- First report of carbapenemase-producing bacteria from poultry farms in the United Arab Emirates: an emerging One Health threat.Frontiers in veterinary science · 2026Article
- Captive ungulates as sentinels of antimicrobial resistance: genomic and phenotypic characterization of extended-spectrum β-lactamase-producingFrontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poultry production plays a vital role in ensuring food security and nutritional sustainability in the United Arab Emirates (UAE). However, the emergence and spread of antimicrobial-resistant bacteria in poultry farms present a growing public health concern in the region. To address this gap, this study investigated the prevalence and genetic basis of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria in cecal contents of chickens collected from two major poultry farms in Al Ain, UAE. Methods: A total of 77 samples were collected over an eleven-month period, yielding 146 non-duplicate Gram-negative isolates, of which Results: Phenotypic characterization revealed high rates of ESBL production (87.7%), with 95% of Conclusion: Our findings underscore the potential zoonotic risk posed by these strains and highlight the urgent need for strengthened antimicrobial stewardship, enhanced biosecurity practices, and continuous surveillance to limit the spread of resistant bacteria in poultry production and protect public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.